HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cornelia M van Duijn Selected Research

adducin

1/2009Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction.
12/2006Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk.
10/2006The alpha-adducin gene is associated with macrovascular complications and mortality in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cornelia M van Duijn Research Topics

Disease

44Alzheimer Disease (Alzheimer's Disease)
11/2022 - 06/2002
23Type 2 Diabetes Mellitus (MODY)
01/2023 - 03/2002
21Dementia (Dementias)
08/2023 - 09/2003
20Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 02/2003
19Hypertension (High Blood Pressure)
04/2024 - 02/2004
16Obesity
11/2023 - 12/2007
16Myocardial Infarction
09/2013 - 03/2002
13Insulin Resistance
12/2022 - 02/2004
12Genetic Risk Score
04/2024 - 12/2008
12Cognitive Dysfunction
01/2022 - 08/2003
11Macular Degeneration (Age-Related Maculopathy)
01/2022 - 04/2004
11Inflammation (Inflammations)
12/2019 - 11/2006
11Coronary Disease (Coronary Heart Disease)
12/2016 - 01/2006
10Stroke (Strokes)
08/2023 - 10/2002
10Atherosclerosis
12/2016 - 04/2004
9Coronary Artery Disease (Coronary Atherosclerosis)
10/2017 - 08/2010
7Glaucoma
02/2024 - 08/2007
6Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
01/2022 - 05/2004
6Chronic Obstructive Pulmonary Disease (COPD)
07/2020 - 01/2014
6Genetic Predisposition to Disease (Genetic Predisposition)
01/2020 - 12/2010
6Gout
10/2019 - 12/2008
6Heart Failure
01/2019 - 08/2004
5Mental Disorders (Mental Disorder)
03/2023 - 10/2009
5Open-Angle Glaucoma (Glaucoma, Open Angle)
02/2023 - 01/2012
5Migraine Disorders (Migraine)
11/2021 - 08/2011
5Atrophy
01/2021 - 10/2004
5Neoplasms (Cancer)
10/2016 - 02/2008
5Hemochromatosis (Bronze Diabetes)
01/2012 - 11/2002
4Disease Progression
01/2022 - 07/2007
4Down Syndrome (Down's Syndrome)
01/2015 - 07/2009
4Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2010 - 04/2008
3Liver Diseases (Liver Disease)
11/2023 - 10/2011
3Sporadic Creutzfeldt-Jakob Disease
03/2021 - 10/2009
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2021 - 01/2020
3Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2020 - 10/2009
3Osteoarthritis
01/2016 - 04/2004
3Hypercholesterolemia
01/2016 - 01/2004
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2016 - 05/2013
3Parkinson Disease (Parkinson's Disease)
01/2016 - 01/2003
3Carcinogenesis
12/2010 - 03/2008
3Birth Weight (Birth Weights)
05/2010 - 03/2002
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2009 - 01/2008
3Stomach Neoplasms (Stomach Cancer)
03/2008 - 01/2007
2Cerebral Small Vessel Diseases
08/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

29LipidsIBA
12/2022 - 01/2007
23Proteins (Proteins, Gene)FDA Link
11/2023 - 06/2002
20Glucose (Dextrose)FDA LinkGeneric
01/2023 - 12/2007
20Apolipoproteins E (ApoE)IBA
01/2021 - 11/2002
17Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2009
16CholesterolIBA
02/2023 - 02/2004
15Amyloid (Amyloid Fibrils)IBA
01/2022 - 06/2002
15ApolipoproteinsIBA
01/2020 - 11/2002
15Insulin-Like Growth Factor I (IGF-1)IBA
01/2019 - 03/2002
13Insulin (Novolin)FDA Link
12/2022 - 03/2002
11HDL CholesterolIBA
11/2017 - 02/2004
10HDL LipoproteinsIBA
01/2021 - 06/2007
9Amyloid beta-PeptidesIBA
11/2022 - 08/2002
9LDL CholesterolIBA
12/2021 - 08/2010
8Triglycerides (Triacylglycerol)IBA
12/2022 - 04/2010
8Codon (Codons)IBA
01/2022 - 08/2003
7Prion ProteinsIBA
03/2021 - 08/2003
7Retinaldehyde (Retinal)IBA
01/2021 - 08/2006
7Lipoproteins (Lipoprotein)IBA
12/2020 - 12/2009
7AdiponectinIBA
09/2019 - 02/2010
7EnzymesIBA
01/2013 - 07/2007
6Uric Acid (Urate)IBA
10/2019 - 12/2008
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2008 - 02/2004
4Blood Proteins (Serum Proteins)IBA
11/2023 - 10/2012
4P-2 (P 2)IBA
02/2016 - 05/2010
4oxidized low density lipoproteinIBA
01/2016 - 09/2013
4IronIBA
01/2012 - 10/2002
4Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2011 - 02/2005
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2010 - 11/2002
4Antihypertensive Agents (Antihypertensives)IBA
08/2009 - 02/2004
4Cholesterol Ester Transfer ProteinsIBA
09/2007 - 06/2007
3Metformin (Glucophage)FDA LinkGeneric
01/2022 - 10/2015
3Amino AcidsFDA Link
11/2021 - 01/2018
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 01/2012
3Glycoproteins (Glycoprotein)IBA
12/2020 - 10/2011
3LeptinIBA
12/2020 - 09/2014
3Complement System Proteins (Complement)IBA
12/2020 - 07/2006
3Valine (L-Valine)FDA Link
01/2020 - 01/2012
3Transcription Factors (Transcription Factor)IBA
03/2019 - 12/2010
3SmokeIBA
11/2018 - 11/2007
3CreatinineIBA
01/2018 - 04/2004
3Peptides (Polypeptides)IBA
01/2017 - 01/2015
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2016 - 08/2010
3C-Reactive ProteinIBA
06/2015 - 04/2010
3AntioxidantsIBA
03/2014 - 08/2004
3Complement Factor H (Factor H)IBA
01/2013 - 07/2006
314-3-3 Proteins (14-3-3 Protein)IBA
10/2012 - 01/2009
3CytokinesIBA
01/2012 - 11/2006
3Sirtuin 1IBA
05/2010 - 03/2009
3Interleukin-1 (Interleukin 1)IBA
04/2010 - 04/2004
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2009 - 03/2008
3adducinIBA
01/2009 - 10/2006
3Cytochrome P-450 CYP2E1 (CYP2E1)IBA
09/2008 - 01/2007
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2022 - 11/2017
2Phosphatidylcholines (Phosphatidylcholine)IBA
12/2022 - 11/2017

Therapy/Procedure

11Therapeutics
08/2023 - 07/2004